Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

The Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) - Design and Build

  • First published: 19 December 2024
  • Last modified: 19 December 2024
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
ocds-h6vhtk-046b76
Published by:
The Pirbright Institute
Authority ID:
AA28260
Publication date:
19 December 2024
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

A joint initiative between the Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation (UKRI), the Foreign, Commonwealth and Development Office (FCDO) and the Bill & Melinda Gates Foundation will see the creation of a new centre at The Pirbright Institute designed to accelerate the development of animal vaccines to combat emerging and urgent infectious diseases.

The consequences of livestock disease can be catastrophic. As well as posing a very real risk to global food security and international trade, livestock disease also presents a significant threat to global human health due to its pandemic potential.

While the UK remains a world-leader in the early-stage development of vaccines for both human and veterinary medicine, globally we need to strengthen our collective capacity to translate scientific discoveries into solutions for the most challenging veterinary infectious diseases.

The new Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) will bridge the gaps between research and expertise in process development and manufacturing while strengthening the UK's own emergency response capacity and capability. It will bring about tangible health and economic benefits by focusing on diseases prevalent in low- and middle-income countries.

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

THE PIRBRIGHT INSTITUTE

04394007

THE PIRBRIGHT INSTITUTE

WOKING

GU240NF

UK

Contact person: John Nixon

Telephone: +44 1483232441

E-mail: john.nixon@pirbright.ac.uk

NUTS: UKJ25

Internet address(es)

Main address: http://www.pirbrightinnovations.co.uk/

I.4) Type of the contracting authority

Other: Institute

I.5) Main activity

Other: Animal Research

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

The Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) - Design and Build

Reference number: CVIM/D&B/2024

II.1.2) Main CPV code

45214610

 

II.1.3) Type of contract

Works

II.1.4) Short description

A joint initiative between the Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation (UKRI), the Foreign, Commonwealth and Development Office (FCDO) and the Bill & Melinda Gates Foundation will see the creation of a new centre at The Pirbright Institute designed to accelerate the development of animal vaccines to combat emerging and urgent infectious diseases.

The consequences of livestock disease can be catastrophic. As well as posing a very real risk to global food security and international trade, livestock disease also presents a significant threat to global human health due to its pandemic potential.

While the UK remains a world-leader in the early-stage development of vaccines for both human and veterinary medicine, globally we need to strengthen our collective capacity to translate scientific discoveries into solutions for the most challenging veterinary infectious diseases.

The new Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) will bridge the gaps between research and expertise in process development and manufacturing while strengthening the UK's own emergency response capacity and capability. It will bring about tangible health and economic benefits by focusing on diseases prevalent in low- and middle-income countries.

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 6 417 069.73  GBP

II.2) Description

II.2.3) Place of performance

NUTS code:

UKJ25

II.2.4) Description of the procurement

Procurement Route - Design and Build

Tender Strategy - 'Open Procedure' Single Stage Tender

Design Stage - Stage 3

Form of Contract - NEC4 Option A: Fixed Price with Activity Schedule

The successful Contractor will be responsible for designing and building a c.590m2 new-build facility for The Pirbright Institute, c.461m2 of functional space on the ground floor and c.129m2 of plant space on the first floor.

1) General building outline: New build facility, 590m2, two story above ground, with all functions on ground floor, and plant room on the first floor, comprising of 1 nr GMP cleanroom (ISO007), 1 nr cold-room (CNC), 1 nr freezer room, RM Storage and receipt areas, 1 nr QC Micro lab (CNC), 1 nr QC lab (CNC), a write up area/office and all supporting areas including a plant room and associated external works.

2) The building will be constructed within the existing Pirbright site.

3) Achieve Part L - 2, target for Net Zero Carbon (NZC).

The design of the facility will include biocontainment (ACDP CL2/SAPO2/GMO2), BREEAM: Very Good, cleanrooms (up to ISO7), good manufacturing practice (GMP), net-zero carbon and equity, diversity and inclusion (EDI). The project team that developed the RIBA Stage 3 design in conjunction with the end-user requirements were as follows.:

• Project Manager - Currie and Brown

• Cost Manager - Turner and Townsend

• Multi-Disciplinary Design Consultant / CMT - Scitech

Following the publication of F01: Prior information notice (PIN) 2023/S 000-013633 on 12th May 2023 which was published to establish interest within the market and to help inform us on a number of strategic decisions in relation to this procurement, and determine our strategy a second PIN 2024/S 000-002555 was published on 25th January 2024 to advise of the planned future procurement. We have determined that a Design and Build, 'Open Procedure' Single Stage Tender offers the quickest route to completion whilst still meeting competition.

Along with this F02: Contract Notice a Contracts Finder Notice will be published on the same day and referenced in VI.3 Additional information of this F02: Contracts Notice (see below). With the ITT (Invitation to Tender) Pack or a least some of it being upload as attachments on to the Contracts Finder Notice (the remaining Appendix/documents will be available on receipt of a completed and signed of a Confidentiality Agreement see in VI.3 Additional information below. The ITT package will also be available on demand from procurement@pirbrightinnovations.co.uk. The RIBA stage 3 information will be included in the ITT pack. The Contractor will tender the works on an RIBA Stage 3 design which will form part of the contract documentation, the Contractor as part of their contractual obligations shall further develop the design making design submissions post-contract for approval by the Project Manager and the compliance monitoring team.

The contract proposed is NEC4 Option A: Fixed Price with Activity Schedule with 'Z Clauses' that will be included in 'draft' as part of the ITT pack.

The 'desired' completion date is January 2026. At this point, a planning consultant has been engaged but the project is still subject to a planning submission and approval - the Contractor would be responsible for discharging residual planning conditions as required. The Contractor shall also be responsible for discharging residual BREEAM conditions (will be included within tender pack) and taking on the net-zero carbon philosophy received to completion.

two.2.5) Award criteriaII.2.5) Award criteria

II.2.5) Award criteria

Quality criterion: Quality (Written Response) / Weighting: 60

Quality criterion: Quality (Presentation) / Weighting: 10

Price / Weighting:  30

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2024/S 000-016505

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

12/12/2024

V.2.2) Information about tenders

Number of tenders received: 4

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Scitech Engineering Ltd

04341006

Scitech House, Mill Lane

Godalming

GU7 1EY, UK

UK

NUTS: UKJ25

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 6 417 069.73  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.4) Procedures for review

VI.4.1) Review body

NEC

London

UK

VI.5) Date of dispatch of this notice

17/12/2024

Coding

Commodity categories

ID Title Parent category
45214610 Laboratory building construction work Construction work for buildings relating to education and research

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
john.nixon@pirbright.ac.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.